Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Target Dosage of Continuous Atracurium Infusion at a Moderate Level of Paralysis in Intensive Care Unit Patients Monitored by an Electromyography-Based Quantitative Neuromuscular Monitor

NCT07807046 is registered in ClinicalTrials.gov with Fu Jen Catholic University Hospital as lead sponsor.

NCT NCT07807046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07807046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Target Dosage of Continuous Atracurium Infusion at a Moderate Level of Paralysis in Intensive Care Unit Patients Monitored by an Electromyography-Based Quantitative Neuromuscular Monitor
Lead sponsor
Fu Jen Catholic University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
August 19, 2026
Completion date
July 31, 2028
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ards, ecmo, neuromuscular blockade monitoring, ttm